Oncology Tube - Melissa L. Johnson, MD from Sarah Cannon Cancer Center speaks about A phase 1 study of AMG 757, a half-life extended bispecific T-cell engager...
Oncology Tube - Melissa L. Johnson, MD from Sarah Cannon Cancer Center speaks about A phase 1 study of AMG 757, a half-life extended bispecific T-cell engager...
A phase 1 study of AMG 757 Melissa L. Johnson, MD @MLJohnsonMD2 @SarahRCannon #AMG757 #BiTE #SCLC #LungCancer #Cancer #Research Link To FULL Video: https://t.co/LQ1vjoEDMa https://t.co/LQ1vjoEDMa